| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a3e4a4d5a94954bfbbdbce5a91ab46 |
| publicationDate |
1997-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5679715-A |
| titleOfInvention |
Method for treating multiple sclerosis |
| abstract |
The invention relates to a method of treating multiple sclerosis comprising administering an effective amount of (R)-(-)-N,2-dimethyl-N-2-propynylphenethylamine alone or in conjunction with an effective amount of interferon beta or an effective amount of amantadine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006089066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007048255-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009234021-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005065219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006276537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008279819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087073-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004141947-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087073-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7732407-B2 |
| priorityDate |
1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |